Volume 25, Issue 4 (2022)
mjms 2022, 25(4): 37-42 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Izadikia H, radjabalizadeh K. Molecular study of patients with thalassemia major in Ardabil Province. mjms 2022; 25 (4) :37-42
URL: http://mjms.modares.ac.ir/article-30-55748-en.html
URL: http://mjms.modares.ac.ir/article-30-55748-en.html
1- Ardabil University of Medical Sciences - Imam Reza Hospital, Ardabil, Iran
2- Department of Biology , Ardabil Branch, Islamic Azad University, Ardabil, Iran ,keyradj@gmail.com
2- Department of Biology , Ardabil Branch, Islamic Azad University, Ardabil, Iran ,
Abstract: (1963 Views)
Thalassemia is a common disease caused by mutations in the beta globins gene. Today, this disease is high frequency due to some factors including lack of control, the increase of population growth, and lack of implementation of appropriate methods of family planning. In present study, the molecular β-thalassemia has been investigated in patients with thalassemia major in Ardabil, Iran. Blood samples of patients were collected over the province and in the process of collecting; sampling of venous blood was performed under blood expert guidance and with the consent of 50 patients with β-thalassemia major. The samples were stored at -70 ºC in the freezer and DNA after extraction was amplified by amplification refractory mutation system - polymerase chain reaction (ARMS-PCR) method. The results showed that the frequency of mutation was 16%, 14% and 4% for IVSI-110, IVSII-1 and IVSI-5 mutations, respectively. It can be concluded that the incidence of β-thalassemia major in Ardabil IVSI-110 has the highest ratio of the disease, IVSII-1 is in the second place and IVSI-5 has a bit effect on the creation of thalassemia major patients. It is recommended to create a database of mutations in β-thalassemia patients to find appropriate therapeutic solutions.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |